Xeris Biopharma Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing’s syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Xeris Biopharma Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Xeris Biopharma Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Xeris Biopharma Holdings Inc. is XERS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Xeris Biopharma Holdings Inc. has its primary listing on NASDAQ. You can trade Xeris Biopharma Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Xeris Biopharma Holdings Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Xeris Biopharma Holdings Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Xeris Biopharma Holdings Inc..